| Patents for A61P 29 - Non-central analgesic, antipyretic or antiinflammatory agents, e.g antirheumatic agents; Non-steroidal antiinflammatory drugs (nsaids) (127,169) |
|---|
| 02/01/2012 | CN102341114A Plant extract compositions for prevention and treatment of influenza |
| 02/01/2012 | CN102341112A Method and means for producing tissues and tissues obtained |
| 02/01/2012 | CN102337268A Human CTRP4 gene, its coding protein and their application |
| 02/01/2012 | CN102337042A Preparation method of liquorice pigment |
| 02/01/2012 | CN102336834A Fully human TNFalpha-Fab antibody and its PEG antibody |
| 02/01/2012 | CN102336812A Polypeptide possessing angiogenesis inhibitory activity |
| 02/01/2012 | CN102336811A Novel small peptide capable of inhibiting new vessels and application thereof |
| 02/01/2012 | CN102336716A 嘧啶衍生物 Pyrimidine derivatives |
| 02/01/2012 | CN102336714A Hydantoin ibuprofen derivative and synthetic method and application thereof |
| 02/01/2012 | CN102335418A Health-care wine for relieving rheumatoid swelling |
| 02/01/2012 | CN102335410A Traditional Chinese medicine composition for treating rheumatoid arthritis and application thereof |
| 02/01/2012 | CN102335387A Traditional Chinese medicine composition for treating liver stagnation, improving appetite and promoting digestion and preparation method thereof |
| 02/01/2012 | CN102335386A Chinese medicinal composition for dispersing qi depression, promoting appetite, removing stagnation and stopping pain and preparation method thereof |
| 02/01/2012 | CN102335337A Antirheumatic and body-building snake medical wine |
| 02/01/2012 | CN102335326A Chinese medicinal composition for invigorating circulation of blood to dissipate blood stasis and reducing swelling and relieving pain |
| 02/01/2012 | CN102335317A Cold-prevention and body-building snake medical wine |
| 02/01/2012 | CN102335308A Traumatic injury medicinal liquor |
| 02/01/2012 | CN102335307A Traditional Chinese medicinal composition able to relax muscles, stimulate blood circulation, disperse blood stasis and relieve pain, and its preparation method |
| 02/01/2012 | CN102335304A Chinese medicine composition for dispelling wind, removing dampness, invigorating blood circulation, and relieving pain and preparation method thereof |
| 02/01/2012 | CN102335299A Medicament for treating traumatic injury |
| 02/01/2012 | CN102335296A Refreshing, inflammation eliminating and pain relieving ointment |
| 02/01/2012 | CN102335290A Antirheumatic and hyperglycemic snake medical wine |
| 02/01/2012 | CN102335289A Snake medicinal liquor for removing rheumatism and reducing hypertension |
| 02/01/2012 | CN102335283A Snake medicinal wine for removing wind-dampness |
| 02/01/2012 | CN102335274A Chinese medicinal composition for preventing and treating inflammation-related diseases |
| 02/01/2012 | CN102335271A Preparation method and quality control method of heartleaf houttuynia herb injection |
| 02/01/2012 | CN102335245A Capsule for treating rheumatoid arthritis |
| 02/01/2012 | CN102335237A Plaster for treating cancer pain and preparation method thereof |
| 02/01/2012 | CN102335224A Method for cellulase and ultrasonic wave assisted extraction of flavonoids in peanut hull |
| 02/01/2012 | CN102335211A Application of andrographis paniculata nees extract and chemical components thereof in preparation of medicines used for treating pathological angiogenesis diseases |
| 02/01/2012 | CN102335184A Application of 5,6,7,4'-tetrahydroxyflavone and derivatives thereof as JAK tyrosine protein kinase inhibitor |
| 02/01/2012 | CN102335179A Alprostadil composite medicine, preparation method thereof, quality controlling method thereof, and purpose thereof |
| 02/01/2012 | CN102335174A Application of neferine to preparation of medicine for CCL5 (CC chemokine ligand 5) and CCR5 (CC chemokine Receptor 5) mediated diabetes mellitus complicated by sympathetic nerve/cardiovascular disease |
| 02/01/2012 | CN102335173A Polymorphic forms of 3-(4-amino-1-oxo-1,3 dihydro-isoindol-2-yl)-piperidine-2,6-dione |
| 02/01/2012 | CN102335170A Ketorolac tromethamine medicament absorbed through oral mucosa |
| 02/01/2012 | CN102335156A Etodolac double-layered osmotic pump controlled release tablets, and preparation method thereof |
| 02/01/2012 | CN102335146A Injectable drug combination and preparation method thereof |
| 02/01/2012 | CN102335114A Stable ibuprofen arginine injection and preparation method thereof |
| 02/01/2012 | CN102120013B 祛湿除痹的茶 Dampness chubi tea |
| 02/01/2012 | CN102068534B 一种用于舒筋活络的中药组合物及其制备方法 A Shujin Chinese medicine composition and its preparation method |
| 02/01/2012 | CN101966147B 布洛芬注射液组合物及其制备方法 Ibuprofen Injection composition and its preparation method |
| 02/01/2012 | CN101961467B 膝痹宁及其制备方法和应用 Knee paralysis rather its preparation method and application |
| 02/01/2012 | CN101869607B 对风寒湿所致关节不适有预防保健作用的喷剂及制备方法 Joint discomfort due to wind cold spray and preparation method has the role of preventive health care |
| 02/01/2012 | CN101862628B 一种生物可降解微胶囊化辣椒素及其制备方法 A biodegradable microcapsules of capsaicin and its preparation method |
| 02/01/2012 | CN101822670B 小檗碱在制备防治类风湿关节炎的药物中的应用 Berberine in the manufacture of drug prevention and treatment of rheumatoid arthritis in |
| 02/01/2012 | CN101766773B 一种治疗足跟痛病的中药 A traditional Chinese medicine treatment of heel pain disease |
| 02/01/2012 | CN101711807B 消炎抗菌药膏 Anti-inflammatory anti-bacterial ointment |
| 02/01/2012 | CN101358225B 高唾液酸含量的免疫球蛋白抗体的制备方法与应用 Preparation of high sialic acid content and application of immunoglobulin antibody |
| 02/01/2012 | CN101347408B 青藤碱静脉输液制剂 Sinomenine intravenous infusion formulations |
| 02/01/2012 | CN101264090B 一种治疗牙疼的药物 A method of treating toothache medicine |
| 02/01/2012 | CN101124213B 磺酰氨基环状衍生物及其应用 Sulphonamido cyclic derivatives and its application |
| 02/01/2012 | CN101112423B 用于针刀中药植入疗法治疗颈、肩、腰、腿痛的药物组合物 Knife medicine implant therapy for the neck, shoulders, waist, leg pain pharmaceutical composition |
| 01/31/2012 | US8106218 Pharmaceutical compounds |
| 01/31/2012 | US8106214 2-imino-4-(thio) oxo-5-polycyclovinylazolines for use as PI3 kinase inhibitors |
| 01/31/2012 | US8106153 Ex-vivo priming for generating cytotoxic T lymphocytes specific for non-tumor antigens to treat autoimmune and allergic disease |
| 01/31/2012 | US8106097 Composition based on substituted 1,3-diphenylprop-2-en-1-one derivatives, preparation and uses thereof |
| 01/31/2012 | US8106068 Compositions and methods for modulating c-kit and PDGFR receptors |
| 01/31/2012 | US8106063 Pyrimidyl sulphone amide derivatives as chemokine receptor modulators |
| 01/31/2012 | US8106046 Cyclopentathiophene modulators of the glucocorticoid receptor, AP-1, and/or NF-κB activity and use thereof |
| 01/31/2012 | US8106018 Chimeric toll-like receptor/MD-2 polypeptides and methods of use thereof |
| 01/31/2012 | US8105599 Administering a compound which binds to a C-type lectin on the surface of a dendritic cell, with the proviso that the C-type lectin is not the DEC-205 receptor |
| 01/31/2012 | CA2516698C Novel transcriptional factor, process for producing the same and use thereof |
| 01/31/2012 | CA2508022C Mastitis treatment |
| 01/31/2012 | CA2463989C Pyrimidine derivatives, pharmaceutical compositions containing these compounds, the use thereof and process for the preparation thereof |
| 01/31/2012 | CA2393682C Depsipeptide and congeners thereof for use as immunosuppressants |
| 01/26/2012 | WO2012012667A2 Methods and compositions for modification of a hla locus |
| 01/26/2012 | WO2012012509A1 Corrosion current-generating metal particulates and use thereof |
| 01/26/2012 | WO2012012390A1 Botanical composition and methods of manufacture and use |
| 01/26/2012 | WO2012012370A1 Vitamin c and chromium-free vitamin k, and compositions thereof for treating an nfkb-mediated condition or disease |
| 01/26/2012 | WO2012012307A1 Sulfonyl compounds which modulate the cb2 rece |
| 01/26/2012 | WO2012012300A2 Adverse side-effects associated with administration of an anti-hyaluronan agent and methods for ameliorating or preventing the side-effects |
| 01/26/2012 | WO2012012278A2 Compositions and methods for the treatment of pathological condition(s) related to gpr35 and/or gpr35-herg complex |
| 01/26/2012 | WO2012012146A2 Compositions and methods to modulate progression and onset of inflammatory bowel disease |
| 01/26/2012 | WO2012011619A1 Method for separating ephedrine from ephedra sinica stapf at a high yield, and adjuvant for enhancing immunity containing ephedrine as an active ingredient |
| 01/26/2012 | WO2012011591A1 Fused heterocyclic compound and application thereof |
| 01/26/2012 | WO2012011123A1 Pyridin- 2 - yl sulfanyl acid esters and process for the preparation thereof |
| 01/26/2012 | WO2012011113A2 Regulatory immune cells with enhanced targeted cell death effect |
| 01/26/2012 | WO2012011112A1 Non psychoactive cannabinoids and uses thereof |
| 01/26/2012 | WO2012010826A1 Pyrimidine compounds as inhibitors of protein kinases ikk epsilon and/or tbk-1, processes for their preparation, and pharmaceutical compositions containing them |
| 01/26/2012 | WO2011156030A3 High oil-content emollient aerosol foam compositions |
| 01/26/2012 | WO2011139489A3 Compounds that modulate intracellular calcium |
| 01/26/2012 | US20120023600 Compositions and methods of use for antibodies of dickkopf-1 |
| 01/26/2012 | US20120022236 Recombinant Anti-VLA4 Antibody Molecules |
| 01/26/2012 | US20120022155 Use of aminaphtone for the preparation of a medicament for treating arteriopathies |
| 01/26/2012 | US20120022154 N-hydroxy c29-amide derivatives of oleandrane |
| 01/26/2012 | US20120022147 2, 6 xylidine derivatives for the treatment of pain |
| 01/26/2012 | US20120022143 RNA Interference Mediated Inhibition of the Thymic Stromal Lymphopoietin (TSLP) Gene Expression Using Short Interfering Nucliec Acid (siNA) |
| 01/26/2012 | US20120022139 Short Interfering Ribonucleic Acid (siRNA) for Oral Administration |
| 01/26/2012 | US20120022138 Means for inhibiting the expression of ang2 |
| 01/26/2012 | US20120022129 Targeting of Histone Deacetylase 2, Protein Kinase CK2, and Nuclear Factor NRF2 For Treatment of Inflammatory Diseases |
| 01/26/2012 | US20120022119 Heterocyclic antagonists of prostaglandin d2 receptors |
| 01/26/2012 | US20120022117 Salts or Co-Crystals of 3-(3-dimethylamino-1-ethyl-2-methyl-propyl)-phenol |
| 01/26/2012 | US20120022116 Compositions and methods for the treatment of pathological condition(s) related to gpr35 and/or gpr35-herg complex |
| 01/26/2012 | US20120022109 Oxadiazole derivatives |
| 01/26/2012 | US20120022092 Protein kinase c inhibitors and uses thereof |
| 01/26/2012 | US20120022081 Method of using diketopiperazines and composition containing them |
| 01/26/2012 | US20120022076 Derivatives of n-(arylamino)sulfonamides as inhibitors of mek |
| 01/26/2012 | US20120022070 Heat Shock Protein 90 Inhibitors, Methods Of Preparing Same, And Methods For Their Use |
| 01/26/2012 | US20120022067 Thiazole and oxazole-substituted arylamides as p2x3 and p2x2/3 antagonists |
| 01/26/2012 | US20120022058 4,5-dihydro-1h-pyrazole compounds and their pharmaceutical uses |